The Centers for Medicare & Medicaid Services late today announced proposed changes to the Medicare Advantage and Part D prescription drug programs for calendar year 2016, which would reduce payments by a net 0.95%. When combined with expected growth in plan risk scores due to coding, CMS said the changes would increase revenue for MA plans and Part D sponsors by an average 1.05%. Among other policy changes, CMS proposes to reiterate existing rules requiring Medicare Advantage organizations to maintain accurate provider network directories for enrollees; reduce the weight of seven measures in its star rating system to counterbalance the lack of socioeconomic adjustments; and publish information on access to preferred cost sharing pharmacies for each Part D plan offering a preferred cost sharing benefit structure. CMS will accept comments on the 2016 Advance Notice and Draft Call Letter through March 6, and expects to publish a final rate announcement and call letter on April 6.

Headline
The AHA Oct. 20 expressed support for the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act (S. 1974), bipartisan legislation designed…
Headline
The median annual net launch price for new prescription drugs increased 35% from 2022 to 2025, to $257,000, according to a report released by the Institute for…
Headline
The Centers for Medicare & Medicaid Services Oct. 20 published two qualifying payment amount audits under the No Surprises Act. The audits were of…
Headline
AHA leaders this week are participating in the International Hospital Federation’s 2026 World Hospital Congress in Seoul, South Korea. On Oct. 20, Bill Gassen…
Headline
In this conversation, Amy Lee, president and chief operating officer at Nantucket Cottage Hospital, shares how telehealth is transforming patient care on the…
Headline
The National Security Agency has issued guidance on reducing the risk of simple network management protocol abuse. SNMP consists of a standardized framework…